Loading...
MYC copy gain, chromosomal instability and PI3K activation as potential markers of unfavourable outcome in trastuzumab-treated patients with metastatic breast cancer
BACKGROUND: There is an unmet need for more efficient patient stratification for receiving trastuzumab in the metastatic breast cancer (mBC) setting, since only part of such patients benefit from the addition of this agent to chemotherapy. The aim of this study was to investigate the prognostic valu...
Na minha lista:
| Udgivet i: | J Transl Med |
|---|---|
| Main Authors: | , , , , , , , , , , , , , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
BioMed Central
2016
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4869295/ https://ncbi.nlm.nih.gov/pubmed/27184134 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12967-016-0883-z |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|